Main Article Content

Authors

 

Objective: to quantify placenta-specific RNA in plasma of women carrying foetuses with intrauterine growth restriction and

pregnant women with normal pregnancies.

Materials and methods: 8 pregnant women with foetuses with intrauterine growth restriction were studied as well as 18

women with uncomplicated pregnancies in the third pregnancy trimester. Total free RNA was quantified in maternal plasma

by spectrophotometry and the gene expression of hPL (Human Placental Lactogen) at the messenger RNA level through

technical Real Time-Chain Reaction Polymerase.

Results: plasma RNA of fetoplacental origin was successfully detected in 100% of pregnant women. There were no statistically

significant differences between the values of total RNA extracted from plasma (p = 0.5975) nor in the messenger RNA

expression of hPL gene (p = 0.5785) between cases and controls.

Conclusion: messenger RNA of fetoplacental origin can be detected in maternal plasma during pregnancy.

 

Ayala Ramírez, P. A., García Robles, R., Rojas Barrera, J. D., Bermúdez, M. C., & Bernal Villegas, J. E. (2012). Identification of messenger RNA of fetoplacental source in maternal plasma of women with normal pregnancies and pregnancies with intrauterine growth restriction. Colombia Medica, 43(3), 184–188. https://doi.org/10.25100/cm.v43i3.863

Molina LM, Barbosa RH. Retardo de crecimiento intrauterino

(RCIU) y sus alteracionesbioquímicas. Nova. 2005(003):88-94.

Kjell Haram ES, Ole Myking. Groeth Restriction: Etiology, Maternal

and Neonatal Outcome. Cirr Wom Health Rev. 2007;3:145-

Kramer MS. The epidemiology of adverse pregnancy outcomes:

an overview. J Nutr. 2003;133(5 Suppl 2):1592S-6S.

Cikot RJ, Steegers-Theunissen RP, Thomas CM, de Boo TM,

Merkus HM, Steegers EA. Longitudinal vitamin and homocysteine

levels in normal pregnancy. Br J Nutr. 2001:49-58.

Markestad T, Bergsjo P, Aakvaag A, Lie RT, Jacobsen G, Hoffman

HJ, et al. Prediction of fetal growth based on maternal serum

concentrations of human chorionic gonadotropin, human placental

lactogen and estriol. Acta Obstet Gynecol Scand Suppl.

;165:50-5.

Pang WW, Tsui MH, Sahota D, Leung TY, Lau TK, Lo YM, et al.

A strategy for identifying circulating placental RNA markers for

fetal growth assessment. Prenat Diagn. 2009;29(5):495-504.

Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman

CW, et al. Presence of fetal DNA in maternal plasma and serum.

Lancet. 1997:485-7.

Bianchi DW. Fetal cells in the maternal circulation: feasibility

for prenatal diagnosis. Br J Haematol. 1999:574-83.

Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in

maternal plasma. Clin Chem. 2000;46(11):1832-4.

Tsui NB, Akolekar R, Chiu RW, Chow KC, Leung TY, Lau TK,

et al. Synergy of total PLAC4 RNA concentration and measurement

of the RNA single-nucleotide polymorphism allelic ratio

for the noninvasive prenatal detection of trisomy 21. Clin Chem.

:73-81.

Tsui NB, Wong BC, Leung TY, Lau TK, Chiu RW, Lo YM.

Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP

allelic ratio analysis using maternal plasma SERPINB2 mRNA: a

feasibility study. Prenat Diagn. 2009;29(11):1031-7.

Arcelli D, Farina A, Cappuzzello C, Bresin A, De Sanctis P, Perolo

A, et al. Identification of circulating placental mRNA in maternal

blood of pregnancies affected with fetal congenital heart diseases

at the second trimester of pregnancy: implications for early

molecular screening. Prenat Diagn. 2010;30(3):229-34.

Shimizu H, Sekizawa A, Purwosunu Y, Nakamura M, Farina A,

Rizzo N, et al. PP13 mRNA expression in the cellular component

of maternal blood as a marker for preeclampsia. Prenat Diagn.

;29(13):1231-6.

Farina A, Sekizawa A, Purwosunu Y, Rizzo N, Banzola I, Concu

M, et al. Quantitative distribution of a panel of circulating mRNA

in preeclampsia versus controls. Prenat Diagn. 2006;26(12):1115-

Masuzaki H, Miura K, Yoshiura K, Yamasaki K, Miura S, Yoshimura

S, et al. Placental mRNA in maternal plasma and its clinical

application to the evaluation of placental status in a pregnant

woman with placenta previa-percreta. Clin Chem. 2005:923-5.

Schmidt M, Hoffmann B, Kimmig R, Kasimir-Bauer S. mRNA

of placental origin in maternal serum of women with normal and

preeclamptic pregnancies. Fetal Diagn Ther. 2009:269-76.

Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS,

et al. mRNA of placental origin is readily detectable in maternal

plasma. Proc Natl Acad Sci 2003:4748-53.

Rozen S, Skaletsky H. Primer3 on the WWW for general users

and for biologist programmers. Methods Mol Biol. 2000;132:365-

Overbergh L, Valckx D, Waer M, Mathieu C. Quantification

of murine cytokine mRNAs using real time quantitative reverse

transcriptase PCR. Cytokine. 1999 Academic Press.; 1999:305-12.

Chiu RW, Lui WB, Cheung MC, Kumta N, Farina A, Banzola

I, et al. Time profile of appearance and disappearance of circulating

placenta-derived mRNA in maternal plasma. Clin Chem.

:313-6.

Okazaki S, Sekizawa A, Purwosunu Y, Iwasaki M, Farina A,

Okai T. Measurement of mRNA of trophoblast-specific genes in

cellular and plasma components of maternal blood. J Med Genet.

England; 2006:e47.

Maron JL, Johnson KL, Slonim D, Lai CQ, Ramoni M, Alterovitz

G, et al. Gene expression analysis in pregnant women and

their infants identifies unique fetal biomarkers that circulate in

maternal blood. J Clin Invest. 2007;117(10):3007-19.

Tsui NB, Chim SS, Chiu RW, Lau TK, Ng EK, Leung TN, et al.

Systematic micro-array based identification of placental mRNA in

maternal plasma: towards non-invasive prenatal gene expression

profiling. J Med Genet. 2004;41(6):461-7.

Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W,

Hahn S. Parallel assessment of circulatory fetal DNA and corticotropin-

releasing hormone mRNA in early- and late-onset preeclampsia.

Clin Chem. 2005:1730-3.

Downloads

Download data is not yet available.
Received 2011-09-12
Accepted 2012-02-17
Published 2012-09-28